Trump Administration’s Impact on Affordable Medication: A Physician’s Perspective
In this video, Dr. Kulmeet Kundlas discusses the historic negotiation by the Trump administration to lower the prices of critical medications like Ozempic and many GLP-1 agonists. Highlighting the significance of GLP-1 agonists in treating obesity and type 2 diabetes, Dr. Kundlas explains how these medications also help prevent conditions such as heart attacks and memory loss. The video explores the efforts to make these drugs affordable through Medicare and Medicaid, and the anticipated changes in out-of-pocket costs starting in 2025. Dr. Kundlas emphasizes the importance of lifestyle changes alongside medical treatments and calls for viewer engagement to support content that simplifies healthcare.
